BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1904281)

  • 1. Age-related alterations in prolactin secretion by individual cells as assessed by the reverse hemolytic plaque assay.
    Larson GH; Wise PM
    Biol Reprod; 1991 Apr; 44(4):648-55. PubMed ID: 1904281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH; Koos RD; Sortino MA; Wise PM
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes.
    Livingstone JD; Lerant A; Freeman ME
    Neuroendocrinology; 1998 Sep; 68(3):172-9. PubMed ID: 9734001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hyperprolactinemia on luteinizing hormone and prolactin secretion assessed using the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Biol Reprod; 1989 Oct; 41(4):618-25. PubMed ID: 2695175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
    Pu HF; Liu TC
    J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine effects on in vitro responsiveness of anterior pituitary hormone release to dopamine and thyrotropin-releasing hormone in young female rats.
    Moreno ML; Villanúa MA; Arce A; Esquifino AI
    J Neuroendocrinol; 1995 Oct; 7(10):765-74. PubMed ID: 8563719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid augmentation of prolactin cell number and secretory capacity by an estrogen-induced factor released from the neurointermediate lobe.
    Ellerkmann E; Nagy GM; Frawley LS
    Endocrinology; 1991 Aug; 129(2):838-42. PubMed ID: 1906805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of guanine nucleotide-binding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropin-releasing hormone signal transduction: evidence for competition and commonality.
    Kineman RD; Gettys TW; Frawley LS
    J Endocrinol; 1996 Mar; 148(3):447-55. PubMed ID: 8778223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient dopamine withdrawal differentially potentiates thyrotropin releasing hormone-induced release of prolactin of various ages.
    Martinez de la Escalera G; Weiner RI
    Neuroendocrinology; 1990 Jun; 51(6):694-9. PubMed ID: 2114004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ovarian steroid hormones on dopamine-controlled prolactin secretory responses in vitro.
    Close FT; Freeman ME
    Neuroendocrinology; 1997 Jun; 65(6):430-5. PubMed ID: 9208405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine.
    Luque EH; Munoz de Toro M; Smith PF; Neill JD
    Endocrinology; 1986 May; 118(5):2120-4. PubMed ID: 3084212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 17 beta-estradiol on phosphoinositide metabolism and prolactin secretion in anterior pituitary cells.
    Kubota T; Kuan SI; MacLeod RM
    Neuroendocrinology; 1989 Oct; 50(4):400-5. PubMed ID: 2554176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
    Burris TP; Nguyen DN; Smith SG; Freeman ME
    Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin release from subpopulations of rat lactotrophs in the presence and absence of dopamine.
    Hu L; Lawson DM
    J Endocrinol; 1996 Jan; 148(1):113-20. PubMed ID: 8568458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related differences in the spontaneous and thyrotropin-releasing hormone-stimulated release of prolactin and thyrotropin in ovariectomized rats.
    Wang PS; Liu JY; Hwang CY; Hwang C; Day CH; Chang CH; Pu HF; Pan JT
    Neuroendocrinology; 1989 Jun; 49(6):592-6. PubMed ID: 2505153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic estrogen treatment in male rats reveals mammosomatotropes and allows inhibition of prolactin secretion by somatostatin.
    Goth MI; Lyons CE; Ellwood MR; Barrett JR; Thorner MO
    Endocrinology; 1996 Jan; 137(1):274-80. PubMed ID: 8536623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of prolactin secretion in normal and estrogen-treated pituitaries of rats at the single cell level: analysis by reverse hemolytic plaque assay.
    Yoshikawa M; Uozumi T; Kawamoto K; Arita K; Ito A; Takahashi S
    Endocr J; 1995 Apr; 42(2):235-43. PubMed ID: 7627268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries.
    Aguilar R; Bellido C; Garrido-Gracia JC; Alonso R; Sánchez-Criado JE
    Reproduction; 2006 Apr; 131(4):763-9. PubMed ID: 16595727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G; Guthrie J; Weiner RI
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.